|
|
|
|
|
|
|
Champions Oncolog (CSBR)
|
|
4.1399 -0.02 (-0.48%)
|
05-22 10:34
|
|
Open:
|
4.15
|
Pre. Close:
|
4.16
|
|
High:
|
4.19
|
Low:
|
4.1399
|
|
Volume:
|
3,207
|
Market Cap:
|
46M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
4.232 - 4.26
|
4.26 - 4.284
|
|
Low:
|
4.105 - 4.133
|
4.133 - 4.156
|
|
Close:
|
4.119 - 4.164
|
4.164 - 4.202
|
|
|
|
Technical analysis (as of: 2018-05-22 11:08:42 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 5.08 One year: 5.52
|
|
Support:
|
Support1: 3.73 Support2: 3.10
|
|
Resistance:
|
Resistance1:
4.35 Resistance2: 4.73
|
|
Pivot:
|
4.33 
|
|
Moving Averages:
|
MA(5): 4.17 MA(20): 4.32
MA(100): 3.88 MA(250): 3.45
|
|
MACD:
|
MACD(12,26):
0.04 Signal(12,26,9): 0.09
|
|
%K %D:
|
%K(14,3): 4.99 %D(3): 8.39
|
|
RSI:
|
RSI(14): 47.62
|
|
52-Week:
|
High: 4.75
Low: 2.19 Change(%): 65.6
|
|
Average Vol(K):
|
3-Month: 2475
10-Days 687
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CSBR has closed above bottom band by 19.8%. Bollinger Bands are 0.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-03T08:30:00-04:00
Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th
2018-05-01T08:30:00-04:00
Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research
2018-04-04T08:30:00-04:00
Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House
2018-03-15T21:13:03-04:00
Champions Oncology's (CSBR) CEO Ronnie Morris on Q3 2018 Results - Earnings Call Transcript
2018-03-15T16:43:20-04:00
Champions Oncology reports Q3 results
2018-03-15T16:01:00-04:00
Champions Oncology Reports Quarterly Revenue of $5.1 Million
2018-03-07T08:30:00-05:00
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018
2018-02-26T08:30:00-05:00
Champions Oncology to Participate at the 30th Annual ROTH Conference
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
